European committee takes a second look at Alzheimer's drug
University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...
A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...
The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, ...
2don MSNOpinion
Alzheimer’s disease robs patients of so much more than their health. It can rewire their personalities and undermine a ...
November is National Alzheimer’s Disease Month, and it’s also Caretaker Month. These two things often go hand-in-hand, but ...
The AD risk factors/hits include high exposure to traffic-related air pollution (TRAP) and infections, as well as factors ...
The EMA’s Committee for Medicinal Products for Human Use has issued a positive recommendation for Eisai and Biogen’s Leqembi ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback